ストックスクリーナーアプリを入手
0.6102
0.78%
-0.0048
アフターアワーズ：
.61
-0.0002
-0.03%
前日終値:
$0.615
開ける：
$0.63
24時間の取引高:
514.88K
Relative Volume:
1.14
時価総額：
$40.76M
収益：
-
当期純損益:
$-126.61M
株価収益率:
-0.3113
EPS:
-1.96
ネットキャッシュフロー:
$-60.14M
1週間 パフォーマンス:
-10.26%
1か月 パフォーマンス:
-38.36%
6か月 パフォーマンス:
-76.44%
1年 パフォーマンス:
-69.94%
1日の値動き範囲:
$0.5854
$0.6392
1週間の範囲:
$0.5854
$0.7516
52週間の値動き範囲:
$0.5854
$4.65
Generation Bio Co Stock (GBIO) Company Profile
GBIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
0.6102 | 40.76M | 0 | -126.61M | -60.14M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-10-19 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2022-11-08 | 開始されました | Canaccord Genuity | Buy |
| 2021-12-14 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-06-08 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-02-24 | 開始されました | William Blair | Outperform |
| 2021-02-18 | 開始されました | Needham | Buy |
| 2020-07-07 | 開始されました | Cowen | Outperform |
| 2020-07-07 | 開始されました | JP Morgan | Overweight |
| 2020-07-07 | 開始されました | Jefferies | Buy |
| 2020-07-07 | 開始されました | Wedbush | Outperform |
すべてを表示
Generation Bio Co (GBIO) 最新ニュース
Generation Bio stock hits 52-week low at $0.6 amid sharp decline - Investing.com
Spore.Bio raises €22 million to deploy a new generation of AI-based microbiology testing - EU-Startups
Layoff Tracker: Kojin Will Soon Close Its Doors, Affecting 25 Employees - BioSpace
Generation Bio stock hits 52-week low at $0.66 By Investing.com - Investing.com Nigeria
Generation Bio stock hits 52-week low at $0.66 - MSN
Insider Buying: Quinn Anthony G., Generation Bio Co [GBIO] Director invested 125,791 shares - Knox Daily
BBAI Stock Sees Surge of Approximately 95.33% in Last Five Days - Knox Daily
Insider Selling: Les Jason, Riot Platforms Inc [RIOT] CHIEF EXECUTIVE OFFICER divested 50,000 shares - Knox Daily
Biotech Executive Powerhouse: Ex-Generation Bio CFO Takes Dual Leadership Role at Rising ADC Developer Tubulis - StockTitan
Pioneering the next generation of bio-based polymers in partnership with London-listed Synthomer - University of York
Ratio Revelations: Generation Bio Co (GBIO)’s Financial Metrics in the Spotlight - The Dwinnex
Generation Bio (GBIO) Stock Price, News & Analysis - MarketBeat
3 US Penny Stocks With Market Cap Under $70M - Yahoo Finance
Generation Bio Co. (NASDAQ:GBIO) Shares Purchased by Barclays PLC - Defense World
Generation Bio chief scientific officer Matthew Stanton to leave role - MSN
Analysts Provide Insight Into Generation Bio Co’s (GBIO) Potential. - Stocks Register
Will Generation Bio (NASDAQ:GBIO) Spend Its Cash Wisely? - Yahoo Finance
Generation Bio Independent Director Acquires 131% More Stock - Yahoo Finance
Generation Bio Co. (NASDAQ:GBIO) Shares Sold by Jane Street Group LLC - Defense World
Generation Bio director Quinn Anthony buys $203k in shares By Investing.com - Investing.com South Africa
Generation Bio Co. (NASDAQ:GBIO) Director Anthony G. Quinn Purchases 125,791 Shares - MarketBeat
Anthony G. Quinn Purchases 85,000 Shares of Generation Bio Co. (NASDAQ:GBIO) Stock - MarketBeat
Generation Bio director Quinn Anthony buys $203k in shares - Investing.com
Seattle immunotherapy startup Umoja Biopharma raises $100M - GeekWire
Needham & Company LLC Issues Pessimistic Forecast for Generation Bio (NASDAQ:GBIO) Stock Price - Defense World
Generation Bio's SWOT analysis: ctLNP tech drives pivot to autoimmune stock - Investing.com Canada
Verdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches with Over $410M in Series A Financing to Advance Next-Generation Therapies - Business Wire
Finance Watch: Generation Bio, CytomX Right-Size Operations Ahead Of J.P. Morgan - News & Insights
Needham & Company LLC Lowers Generation Bio (NASDAQ:GBIO) Price Target to $8.00 - MarketBeat
Barclays PLC Boosts Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Novo Nordisk partners with Variant Bio; Aviceda raises $207M in Series C - Endpoints News
Generation Bio Announces Executive Departures and Appointments - Defense World
Generation Bio Restructures Leadership and Focuses on siRNA - TipRanks
Generation Bio Co. Announces Executive Changes - Marketscreener.com
Generation Bio Co. to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases - Marketscreener.com
Generation Bio Co (GBIO) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):